Taysha Gene Therapies (TSHA) has priced upsized initial public offering of ~7.9M (from 6.8M) shares at $20/share, at the high end of the prior expected range of $18 - $20.
The shares to kick-off trading today on the Nasdaq Global Select Market.
Offering is expected to close on September 28, 2020.
Underwriters' over-allotment is an additional 1,180,434 shares.
https://seekingalpha.com/news/3616954-taysha-gene-therapies-prices-upsized-ipo-20-share
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.